One integrated supply chain for Nigeria's public health system.
ARC_ESM helped turn the National Health Supply Chain Strategy into a State Implementation Blueprint, then worked State by State until DMAs grew from 6 to 26.
From strategy to blueprint
ARC_ESM was part of the multi-partner team that supported the Federal Ministry of Health to develop the National Health Supply Chain Strategy and Implementation Plan 2021–2025.
Following its launch, and through our investment partnership with the Gates Foundation, ARC_ESM was the sole partner that supported the National Product Supply Chain Management Programme (NPSCMP) to develop the National Supply Chain Strategy Blueprint (2021–2025): the framework for implementing the Strategy at Federal and State levels.
The Blueprint sets out the strategic objectives and policy frameworks required at each level, and defines a maturity pathway for State Drug Management Agencies (DMAs), from Rudimentary through Emerging and Maturing to a Matured DMA able to integrate all public health programme supply chains with the essential medicines programme.
ARC_ESM moved beyond developing the document to working with NPSCMP to roll out its implementation across States, with the establishment of State DMAs as a key deliverable of the Strategy. The number of DMAs in Nigeria has grown from 6 in 2020 to 26 today, strengthening State ownership and a more sustainable supply of medicines and health products in pursuit of Universal Health Coverage.
- 01Level 1Rudimentary
- 02Level 2Emerging
- 03Level 3Maturing · Not Ready to Integrate
- 04Level 4Maturing · Ready to Integrate
- 05Level 5Matured
An independent midterm review
Having supported the development of the Blueprint, ARC_ESM was engaged by The Global Fund to step back and provide an independent midterm review of how the country was implementing the National Health Product Supply Chain Strategy and Implementation Plan (NHPSCSP) 2021–2025.
The review assessed performance as at January 2023 against the Strategy’s Monitoring and Evaluation framework across all four pillars – NPSCMP Optimization, Increasing State Ownership and Capacity, Integration of Supply Chains, and Optimizing Supply Chain Functions – at both National and State levels.
Strengthening the national programme that coordinates health product supply chains.
States leading and financing their own supply chains through DMAs.
Bringing public health programme supply chains together with essential medicines.
Improving forecasting, procurement, warehousing, distribution and data.
The review documented key achievements – support to 19 States to adopt the Strategy, National Council on Health approval of DMAs in 2022, and legal backing in 13 States to transform Drug Revolving Funds into DMAs – and set out the steps towards the 2026–2030 Strategic Plan. Read the full review summary.
Results across eleven States
Adoption of the Strategy was only the first step. Through our Gates Foundation investment (2021–2026), ARC_ESM supported eleven States – Kano, Yobe, Kaduna, Lagos, Niger, Nasarawa, Sokoto, Bauchi, Gombe, Borno and Ekiti – to implement the Blueprint and progress along the five-level national maturity pathway towards a Matured, integrated supply chain.
Applying our Thought Leadership, Advisory and Brokering model, we supported States to complete maturity assessments, develop Commissioner-endorsed supply chain workplans, enact DMA legislation, establish dedicated supply chain teams and adopt public-private partnership (PPP) financing models. By December 2024, all eleven States had completed every tracked sustainability milestone.
- Nasarawa · stock-out rateLower is better
- Nasarawa · delivery lead timeLower is better
- Kano · Drug Revolving Fund
How we work with government
Assess the State Drug Management Agency against national governance, strategy and operations criteria.
Co-design a costed, evidence-based supply chain workplan the State owns.
Support the legal backing that turns a Drug Revolving Fund into a DMA.
Set up and coach the State team that will run the plan.
Broker public-private partnerships and financing that keep commodities flowing.
Equipping NPSCMP to lead
Through The Global Fund’s Resilient and Sustainable Systems for Health (RSSH-3/C19RM) grant (2025–2026), with NACA as Principal Recipient, ARC_ESM transferred its State engagement methodology – first developed through Gates Foundation-funded work in six States and later scaled through USAID-funded engagements in twelve – to NPSCMP, equipping the Programme to assess, advise and support States directly, without external technical assistance.
Using a seven-phase capacity transfer model piloted in Abia, Ekiti and Plateau States, the project delivered all approved outputs and exceeded several targets.
Next: the National Supply Chain Integration Architecture
In September 2026 ARC_ESM announced a landmark engagement: the finalisation, operationalisation and institutionalisation of Nigeria's National Supply Chain Integration Architecture, in collaboration with the Federal Ministry of Health and Social Welfare. As a foundational step, CEO Azuka Okeke and team paid a courtesy visit to the Ministry.
Pooled distribution
In Nigeria, a significant share of the cost of essential goods builds up after they leave the manufacturer's or importer's bay – through half-empty trucks, duplicated warehouses and parallel delivery networks serving the same markets and facilities. ARC_ESM's strategic partnership talks with DP World's teams from South Africa and the Netherlands aim to move pooled distribution from ideas to action.
Case study: No More Empty Shelves, Kaduna
With the Kaduna State Government and the Gates Foundation, ARC_ESM designed and implemented a new distribution strategy that gets the right medicines to primary health centres, in the right quantities and on time. Kaduna progressed from Emerging (42%) to Maturing Ready to Integrate, became the first State in Nigeria to reach 100% health facility coverage, and eliminated oxytocin stock-outs across 71 primary health care facilities.
Empty shelves in public clinics do not have to be the norm.